Product Description

Company Introduction


Shanghai Outdo Biotech Co., Ltd is a national high-tech enterprise in Shanghai founded in ***3, subordinate to Shanghai Biochip Co., Ltd.(Biochip National Engineering Center at Shanghai founded in ***1)
With concentration on key stages in clinical translation research and application and related industries development, it strives to build national standard biobank, clinical molecular and translational medicine platform, and personalized precision medicine,
for a complete pattern Sample to Product featuring rapid clinical translation research and precision medicine. 
Based on Patient-Centered(C) goal, Outdo focuses on standardized construction of biobank(B), discipline construction(D), translational research(T) 
and precision medicine(M), concludes CBDTM pattern. 

It can offer services including bio samples storage, guiding biobank foundation, clinical translational medicine projects from samples to products, etc.
Its products focus on clinical translational medicine applications, such as Covid**9 (SARS-Cov*2) Antigen/Antibody rapid test kits, Hp gene mutation test kits, etc. 

Looking for distribution cooperation with friends worldwide.
Welcome to connect! 


Product Intended Use
The Novel Coronavirus (SARS-Cov*2) Antigen Rapid Test kit is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasal Swab samples, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It could be used in conjunction with nucleic acid test to diagnose patients with suspected infection. Results from the Novel Coronavirus (SARS-CoV2) antigen test should not be used as the sole basis for diagnosis, nor for exclusion. The test is in cassette format and intended for professional Medical Institutions use only.
Positive results require further confirmation while negative results do not preclude SARS-CoV*2 infection. Results from this product is for clinical reference only, and further analysis is suggested according to both the clinical symptoms of the patients and the results from the other laboratories.
In the process of using this product, biohazard precautions should be taken according to the guidance or regulations of the specific countries.



Specifications